A Human Clinical Study to Collect Calibration and Performance Data for the RBA-1 and KBS-1
NCT04305938 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2020-03-12
Summary
The purpose of the Kaligia Biosciences KBS Systems 1.0(b) analyte monitoring device is to measure the blood analyte levels in patients. The KBS Systems 1.0(b) device avoids the common practice of accessing the vein to draw blood for conventional laboratory analysis. Instead, the KBS Systems 1.0(b) device uses Raman Spectroscopy to acheive the measurement of various blood analytes through the use of only approximately 40µl of blood. Such a small volume of blood can be sampled via a finger prick procedure rather than needing a larger volume of blood sampled via a venipuncture. The spectra contain information of all the molecules present in the blood (RBCs, hemoglobin, glucose, sodium, potassium, etc.). From these spectra, the system is able to analyze the blood and provide results in a matter of minutes, rather than hours or even, in some cases, days.
Conditions
- Calibration and Validation of Analyte Testing System
Interventions
- DIAGNOSTIC_TEST
-
Minimally invasive and non-invasive blood analyte measurement
Rapid point-of-care minimally invasive blood analyzer consisting of a spectrometer and a computer loaded with Kaligia software that controls the data acquisition and signal processing to interpret blood analyte measurement.
Sponsors & Collaborators
-
Kaligia Biosciences, LLC
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-04-01
- Primary Completion
- 2020-12-31
- Completion
- 2020-12-31
Countries
- United States
Study Locations
More Related Trials
-
Performance Study with the SiMoT System for in Vitro Diagnostic Tests
NCT06518967 ·Status: ACTIVE_NOT_RECRUITING
-
Measuring Alterations of DNA in Human Blood
NCT00178308 ·Status: COMPLETED
-
Equivalence of New Breath AnalyzerCompared to Currently BreathID System in Assessment of Liver Function
NCT02187601 ·Status: COMPLETED ·Phase: NA
-
Liquid Biopsy System Intracoronary Blood Sampling and Analysis to Characterise Disease Biomarkers in Patients With Coronary Disease
NCT06259019 ·Status: RECRUITING ·Phase: NA
-
A Trial to Evaluate the Precision and Accuracy of the NBM-200 Series When Used in a Continuous Prospective Mode
NCT01917487 ·Status: UNKNOWN
-
Tolerability and Background Fluorescence of the MediBeacon Transdermal GFR Measurement System
NCT03810833 ·Status: COMPLETED ·Phase: NA
-
Assessment of Stability of Mail-in Capillary Hemoglobin A1c Test Kit
NCT00511030 ·Status: COMPLETED
-
A Normal Donor Sample Collection Study in Healthy Adults
NCT01318863 ·Status: COMPLETED
-
In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity
NCT04368897 ·Status: WITHDRAWN
-
Collection of Anatomical and Reference Data for Development of a Novel Non-Invasive Lung Hydration Status Technology
NCT02426593 ·Status: COMPLETED
-
QStat Pilot Reference Range Study
NCT04490759 ·Status: COMPLETED
-
StatStrip A Glucose/Creatinine Meter System Lay User Study Evaluation
NCT05144971 ·Status: COMPLETED
-
Collection of Blood Samples for New Diagnostic Devices 2
NCT05568966 ·Status: RECRUITING ·Phase: NA
-
Healthy.io Method Comparison & User Performance Study
NCT02785445 ·Status: COMPLETED ·Phase: NA
-
Clinical Precision and In-use Analyte Stability Study for 19 Parameters in Adult Arterial Whole Blood for PICO70 and SafePICO
NCT06823648 ·Status: COMPLETED
-
Koning Breast Computed Tomography Guided Biopsy
NCT01750320 ·Status: COMPLETED ·Phase: PHASE1
-
Reference Range Study for the Quantra QStat System
NCT04219371 ·Status: COMPLETED
-
ABCA2 GIRMS Analytical Validation Clinical Performance Study
NCT04607304 ·Status: COMPLETED ·Phase: NA
-
Research & Evaluation of LumiraDx SARS-CoV-2 (COVID-19) Point of Care Ab Test
NCT04597047 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Noninvasive Hemoglobin Disposable Sensors
NCT03125031 ·Status: COMPLETED ·Phase: NA
-
Multicenter Performance Study of TriQuik Invitro Diagnostic Device
NCT05293821 ·Status: UNKNOWN
-
Apixaban Validation Study - Additional Study on Fresh Samples
NCT03073265 ·Status: COMPLETED
-
Assessment of Accuracy and Safety of LabTest Checker
NCT05813938 ·Status: COMPLETED ·Phase: NA
-
Noninvasive Measurement of Blood Coagulation
NCT03217799 ·Status: UNKNOWN
-
NOWDx Test for the Detection of Antibodies to COVID-19
NCT04690413 ·Status: COMPLETED ·Phase: NA